Tissue Engineering of Cartilage and Bone

The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.

Chair's Introduction (A. Caplan). Tissue engineering of cartilage: do we need it, can we do it, is it good and can we prove it? (L. Lohmander). Embryonic development and the principles of tissue engineering (A. Caplan). The fundamentals of tissue engineering: scaffolds and bioreactors (G. Vunjak-Novakovic). Tissue-engineered versus native cartilage: linkage between cellular mechano-transduction and biomechanical properties (J. Lee, et al.). From the preclinical model to the patient (E. Hunziker). Mesenchymal stem cell therapy in joint disease (F. Barry). Differentiated chondrocytes for cartilage tissue engineering (J. Huckle, et al.). Mesenchymal stem cells and bioceramics: strategies to regenerate the skeleton (H. Ohgushi, et al.). Bone marrow stromal cells and their use in regenerating bone (R. Cancedda, et al.). Studying the effect of different macrostructures on in vitro cell behaviour and in vivo bone formation using a tissue engineering approach (R. Dekker, et al.). General discussion I Cartilage repair with chondrocytes: clinical and cellular aspects (A. Lindahl, et al.). Qualitative and quantitative in vivo assessment of articular cartilage using magnetic resonance imaging (E. O'Byrne, et al.). Hyaluronan-based scaffolds (Hyalograft(r) C) in the treatment of knee cartilage defects: preliminary clinical findings (A. Pavesio, et al.). Quantitative analysis of repair tissue biopsies following chondrocyte implantation (A. Hollander, et al.). General discussion II: Tissue engineering using recombinant human BMP2. Final discussion and summing-up. Index of contributors. Subject index.